Three multidistrict litigations (MDL) were consolidated after the U.S. Judicial Panel on Multidistrict Litigations (JPML) found that the lawsuits and side effects were similar even though they involved three separate surgical mesh manufacturers, AMS, Boston Scientific, and Ethicon.

The JPML stated that “Centralization therefore will eliminate duplicative discovery; prevent inconsistent pretrial rulings; and conserve the resources of the parties, their counsel and the judiciary,” as well as limit any potential overlap that occurs when you have more than one defendant and product.  This means that since the issues in the separate cases are similar, consolidating (or putting them in the same trial/court) them will avoid duplicating legal procedures when these procedures can be taken in just one event. Instead of going thru three separate trials, there will just be one trial but covering all the issues in the three cases.

The three MDLs ordered for consolidation are:

American Medical Systems, Inc. Pelvic Repair System Products Liability Litigation; Boston Scientific Corp. Pelvic Repair System Products Liability Litigation; and Ethicon, Inc., Pelvic Repair System Products Liability Litigation — MDL No. 2325, MDL No. 2326, and MDL No. 2327, respectively.

The cases involved different designs of transvaginal mesh and pelvic mesh implants. However, the JPML says that despite the difference in the designs, the plaintiffs in each case alleged similar injuries due similar defects that allegedly plague each of the different devices.

Transvaginal mesh complications and injuries have been subject of FDA Safety Warnings as well as Congressional hearings in the last year. Women who have filed vaginal mesh lawsuits claim similar injuries including pelvic pain, mesh erosion, infection, painful intercourse, perforation of the bowel or bladder and the need for corrective surgery.

Read more about transvaginal mesh side effects at http://vaginalmesh.legalview.com/.

After seeking a hearing on the safety of transvaginal mesh, House Democrats are now advancing their campaign for safe and effective medical devices by calling the overhauling of the Food and Drug Administration’s Pre-Market Notification (PMN) Clearance or simply 510(k) Approval System, and thus introducing HR 3847 – a legislation that will allow the FDA to block clearance of devices whose predicates were previously identified with safety issues.

Under Section 510 (k) of the Food, Drug and Cosmetic Act, clearance to medical devices can be granted even without human testing for as long as they are “substantially equivalent” to past devices previously cleared. These ‘past devices’ are called predicates.

Democratic legislators, led by Rep. Edward Markey, D-Mass, are zeroing in at current vaginal mesh products and other medical devices whose predicates were withdrawn from market due to safety issues and defects. Citing injuries from transvaginal implants produced by leading manufacturers, Democrats want the FDA to update the present 510(k) System so that devices with defective predicates are not allowed to be sold without the manufacturers proving first that the new devices do not suffer the defects of its predicates. Democrats basically want that present transvaginal mesh and other medical devices “do not mimic the mistakes made by other products.”

History should not repeat itself. LegalView supports all efforts to make these medical devices safer and more effective. For those suffering from transvaginal mesh injuries, information is available at LegalView on transvaginal mesh devices as well as legal assistance.

The Food and Drug Administration has advised patient to weigh the risks and benefits of using transvaginal mesh devices. LegalView, a leading online legal resource, strives to provide information and free case consultations to women and their families who have been effected by vaginal mesh.

Transvaginal mesh is a surgical mesh used to treat pelvic organ prolapse and incontinence in women. TVM was created due to excellent surgical outcomes using other mesh products. Some of its precedents are surgical success in treating abdonimal wall hernia (around 1950s),  abdominal repair of pelvic organ prolapse (POP) (since 1970s), and urinary stress incontinence (since late 1990s). In hopes that the same device will aid in POP repair, transvaginal mesh was introduced in the field as an alternative to treating prolapsed organs.

Before the advent of transvaginal mesh, traditional non-mesh repair was common to treat prolapsed cases. Absorbable suture materials are used in this procedure. Here, the torn or damaged connective tissue is joined back together by the absorbable suture materials, thus, creating scars to hold them back together. However, the success of the remedy depends fully on the quality of the individual’s own scar tissue formation.

This uncertainty and inconsistency pushed surgeons and researchers to look for other treatment options, including vaginal mesh, where the mesh is inserted through the vaginal to help support the prolapsed organ.

However, many women have reported complications with vaginal mesh, including pain, mesh erosion and mesh shrinkage, all of which impact their quality of life. Because of this, transvaginal mesh is not as successful of a treatment option as hoped.

In fact, this medical marvel has caught Congress’s attention – Congress has requested vaginal mesh hearings to look into the safety of this device.

The still unknown benefits and disadvantages of transvaginal mesh bring about the need for a health care provider’s complete disclosure on this procedure to a patient. If you have experienced vaginal mesh side effects, it will be wise to consult a transvaginal mesh lawyer for possible legal action.

Modern medical devices are fruits of an increasing knowledge and technology in the field of medicine, specifically in pharmacology and surgery. One of these modern medical devices is a vaginal mesh. A medical device surgically implanted, vaginal mesh is intended to correct prolapse or the falling down or slipping of a body part from its usual position or relations. These innovations are intended to bring about cure and better health to those suffering from these physical anomalies.

However, the Food and Drug Administration (FDA) has issued warnings about the side effects that these devices can bring about. The magnitude of this concern has reached Congress such that House Democrats have already called for congressional hearings regarding vaginal mesh devices manufactured by some companies saying “the devices are hazardous to patients.”

Vaginal mesh was thought to be an emerging medical cure. But the fact that the FDA has ordered manufacturers to conduct studies to look into reports of internal injuries caused by these vaginal mesh devices reflects the other side of this supposed medical marvel.

Patients who have undergone surgeries using vaginal mesh have to take legal action and help the authorities in determining the safety of these devices. Congress is making a move. Those who are affected and are potentially vulnerable to these supposed vaginal mesh health hazards should consult their physicians, even if they have not experienced any symptoms.

Women who are currently experiencing symptoms such as vaginal pain, infections, pelvic organ prolapse re-occurrence, or vaginal mesh erosion should immediately consult their physicians for medical attention. Legal action might also be inevitable for those who suffer from vaginal mesh-connected side effects. For additional information about vaginal mesh or to get a free legal consultation, visit http://vaginalmesh.legalview.com.

Let’s hope that Congress acts immediately to review the safety of vaginal mesh and other medical devices. It is hoped that the faster they do this, the safer it is for patients.

According to a recent article by Businessweek, The U.S. Food and Drug Administration wrote a letter to 33 vaginal mesh manufacturers, including Bard and Johnson & Johnson, requiring that the companies study the potential vaginal mesh complications and rates of organ damage. The agency requested three year trials on safety and effectiveness.

Vaginal mesh was originally approved by 501 (k) approval process, where a medical device may be FDA approved if it is similar to other products currently on the market. However in some cases, the original device used to approve newer medical devices was recalled or voluntarily pulled from the market.

Both Johnson & Johnson and Bard have been named in several vaginal mesh lawsuits nationwide, which allege severe complications from the medical device, ranging from mesh erosion, mesh shrinkage, painful sex, severe pain and other complications.

Additional information about vaginal mesh complications can be found at www.legalview.com.

In light of the recent U.S. Food and Drug Administration warnings about vaginal mesh and potential problems associated with other medical devices, the approval process has come under scrutiny.

Currently, the FDA 501 (k) approval process clears newly developed or manufactured medical devices with little testing, as long as the device is similar to another medical device already on the market, known as predicate devices. Bloomberg reports that the 501 (k) process clears close to 90 percent of all medical device applications.

However, if the predicate device is ever recalled or pulled from market due to safety concerns, the similar products given approval through the 501 (k) process are still available. The predicate device for several vaginal mesh products, Boston Scientific’s ProteGen mesh was pulled less than a year after it was approved. ProteGen mesh was used as a predicate device for Johnson & Johnson’s Gynecare TVT, which in turn was used as a predicate device for other vaginal mesh 501(k) approval applications.

These medical devices are still available on the market, even though the original device has been shown to be unsafe for consumers.

As advocates for consumer safety, LegalView urges the revamp of an outdated approval process to better serve the consumers the FDA aims to protect.

For more information about vaginal mesh lawsuits or other medical devices that have been approved via the 501(k) process with the predicate later recalled, please visit LegalView.com.

A new study in the forthcoming issue of The American Journal of Obstetrics and Gynecology found that women who receive vaginal mesh implants for the treatment of pelvic organ prolapse (POP) are more likely to undergo more corrective surgeries than women treated with other methods. Thirty-two women who had vaginal mesh implants and 32 women who received other POP treatments were studied, and the researchers found of the women who underwent vaginal mesh implants, 15.6 percent required additional surgeries within one year of initial treatment.

The researchers also concluded that the women who received other treatments saw a comparable lower rate of re-operation.

Since 2008, the United States Food and Drug Administration (FDA) has been warning health care professionals against using this device. Last July, the FDA issued a formal warning about the advice, advising the general public about it.

Lately, you may have heard a lot about various complications associated with vaginal mesh. Some of the complications include: pain, mesh erosion, mesh shrinkage, and reoccurrence of pelvic organ prolapse (POP) and stress urinary incontinence (SUI) which are the two conditions the device is supposed to treat.

Many women who experience adverse side effects require additional corrective surgeries to correct the complications. Also, since the mesh is designed to grow around human tissue, it is extremely difficult to remove.

While it is difficult to know exactly why these complications can occur, many believe they are due to faulty vaginal mesh products. If you are experiencing any adverse effects of a vaginal mesh implant, it is import that you contact a vaginal mesh lawyer to discuss your rights.

LegalView is made up of four of the nation’s top personal injury law firms and has an excellent reputation. Contact LegalView today for a free legal consult.

Having a vaginal mesh implant can cause several complications, including pain, infection, bleeding, painful urination, and many more. Since 2008, the United States Food and Drug Administration (FDA) has been warning against the use of this device. The agency wanted health care professionals to receive specialized training on how to properly implant the device and warn their patients of any complications they deemed were serious, but rare.

However, those warnings weren’t enough. This year, the FDA released an official warning against the device, citing over one thousand manufacturer complaints regarding serious complications. One of the most commonly and consistently reported complication has been mesh erosion where the mesh erodes into surrounding tissues, making it extremely difficult to remove.

The most recent report from Bloomberg states that there are over 600 vaginal mesh lawsuits currently filed in the United States.

If you suffer from stress urinary incontinence (SUI) or pelvic organ prolapse (POP), your physician may have recommended that you have a vaginal mesh implanted. However, there are many serious complications that you should be aware about.

Some of the complications include: pain, infection, bleeding, painful urination, painful sexual intercourse and mesh shrinkage. The most commonly reported complication is mesh erosion where the mesh erodes into surrounding tissues. Many women need to have several corrective surgeries to alleviate complications, but since the device is designed to grow around human tissue, it is very difficult to remove.

The United States Food and Drug Administration (FDA) has been warning health care professionals about vaginal mesh since 2008, and this year the agency issued a formal warning about the device. The agency even convened a group of outside experts to determine whether or not to ban the device.